ICH
Question one In Japan, Pharmaceuticals and Medical Devices Agency (PMDA) performs both reviews and approval. Question two The dossier package includes compliance with the GLP that stipulates the standards and procedures that must be followed in the development of a new drug. These include the safety issues and clinical trial procedures.
Question threeGiven that there is no any application stage that consumes excess time, the application process takes between 1.9 to 2.5 months.
Question fourApplication Initial interview meeting Questions on key issues Expert review Review report PAFSC evaluation Approval Question five The Japan territory does not have any unique issues in Continue reading...